587|75|Public
500|$|Dermatofibroma (benign <b>fibrous</b> <b>histiocytoma,</b> dermal dendrocytoma, fibrous dermatofibroma, <b>fibrous</b> <b>histiocytoma,</b> fibroma simplex, histiocytoma, nodular subepidermal fibrosis, sclerosing hemangioma) ...|$|E
2500|$|Inflammation in the subcutis {{following}} vaccination {{is considered}} to be a risk factor in the development of VAS, and vaccines containing aluminum were found to produce more inflammation. [...] Furthermore, particles of aluminum adjuvant have been discovered in tumor macrophages. In addition, individual genetic characteristics can also contribute to these injection-site sarcomas. [...] The incidence of VAS is between 1 in 1,000 to 1 in 10,000 vaccinated cats and has been found to be dose-dependent. [...] The time from vaccination to tumor formation varies from three months to eleven years. [...] Fibrosarcoma is the most common VAS; other types include rhabdomyosarcoma, myxosarcoma, chondrosarcoma, malignant <b>fibrous</b> <b>histiocytoma,</b> and undifferentiated sarcoma.|$|E
5000|$|Myxoid {{variant of}} {{malignant}} <b>fibrous</b> <b>histiocytoma</b> (myxofibrosarcoma)(1977) ...|$|E
40|$|Soft-tissue tumors {{developing}} in rats {{at the site}} of implanted Millipore filters showed the structural, cytochemical, and biologic characteristics of the malignant <b>fibrous</b> <b>histiocytomas</b> occurring in man. Evidence from this tumor model suggests that malignant <b>fibrous</b> <b>histiocytomas</b> can arise from pluripotential mesenchymal stem cells which are not derived from the mononuclear/phagocytic system and that chronic inflammation and scarring may predispose to their development...|$|R
50|$|Most {{frequent}} in {{middle-aged and}} older adults (age 40 and above), liposarcomas are {{the second most}} common of all soft-tissue sarcomas following malignant <b>fibrous</b> <b>histiocytomas.</b> Annually 2.5 cases occur per million population.|$|R
40|$|Soft tissue sarcomas {{originating}} in mesenchymal tissue are rarely seen and {{account for only}} 1 % of malignant tumors (1). Malignant <b>fibrous</b> <b>histiocytomas</b> and liposarcomas {{are the most common}} soft tissue sarcomas, with liposarcomas accounting for 20 % (2). Liposarcomas are usually seen in the retroperitoneal regio...|$|R
5000|$|... #Caption: Micrograph {{showing a}} angiomatoid <b>fibrous</b> <b>histiocytoma.</b> H&E stain.|$|E
5000|$|Undifferentiated pleomorphic sarcoma (previously {{referred}} to as Malignant <b>fibrous</b> <b>histiocytoma)</b> ...|$|E
50|$|Angiomatoid <b>fibrous</b> <b>histiocytoma,</b> {{abbreviated}} AFH, is a rarely {{metastasizing tumour}} that affects {{children and young}} adults.|$|E
40|$|<b>Fibrous</b> <b>histiocytomas</b> (FHs) are mesenchymal tumors {{that may}} be benign or malignant. Ocular {{involvement}} by FHs is infrequent and primarily limited to the orbit. Rarely, FHs can also involve the conjunctiva and perilimbal area. We report {{the case of a}} 38 -year-old male with lid, conjunctival, and neck FHs. The diagnosis was confirmed by histopathology...|$|R
40|$|The {{present study}} reports the induction, histopathology, immunocytochemistry, growth pattern and proliferative {{behaviour}} of mesenchymal tumours of the urinary bladder of rats induced {{by a single}} intravesical dose (5 mg/kg/body weight) of N-methyl-N-nitrosourea (MNU). In 14 of 283 female Wistar rats (incidence: 4. 9 %). 16 non-epithelial tumours had developed after an experimental period of 14 months. The most common histological type induced was of fibrohistiocytic origin (eight benign-appearing and three malignant <b>fibrous</b> <b>histiocytomas).</b> Furthermore, two pure histiocytomas (one benign and one malignant) and three capillary and cavernous haemangiomas were produced. Since no metastases occurred and no clear-cut distinction between a merely expansive and a truly invasive growth was possible, the diagnosis of malignancy {{was based on the}} degree of cellular atypia and the mitotic activity. The benign-appearing <b>fibrous</b> <b>histiocytomas</b> showed a mean mitotic index of 0. 06 % and the malignant <b>fibrous</b> <b>histiocytomas</b> of 0. 34 %. The mitotic activity of the malignant histiocytoma was threefold (0. 78 %) as high as in the benign-appearing histiocytoma (0. 25 %). There exist close morphological similarities between the induced mesenchymal tumours in the rat and those occurring in the human bladder. Although the spectrum of histological types of mesenchymal tumours seen in the rat bladder was narrower than that encountered in man, MNU seems suitable for further studying the histogenesis, histopathology and biology of experimentally induced non-epithelial bladder neoplasms to gain information for {{a better understanding of the}} pathogenesis of human disease...|$|R
40|$|The {{authors have}} {{investigated}} a possible relationship between tumor cells of malignant <b>fibrous</b> <b>histiocytomas</b> (MFHs) and histiocytes. This relationship was studied {{by means of}} immunophenotyping using monoclonal antibodies specific for the monocyte cell lineage (FMC- 17, Mac- 1, OKM- 1, Leu-M 1, and lysozyme) and mono- and polyclonal antibodies specific for fibroblasts (respectively, FIB- 86 and FSG). The immunophenotypes of the MFH tumor cells were {{compared with those of}} tumor cells of "true" histiocytic tumors. Monocyte lineage-specific determinants could be demonstrated in varying amounts on cells of the "true" histiocytic tumors but not on cells of MFH or other soft-tissue tumors. The reverse was true for determinants on fibroblasts. The absence of these determinants on malignant histiocytes, and their presence on MFH (and also on benign <b>fibrous</b> <b>histiocytomas,</b> fibrosarcomas, schwannomas, osteosarcomas, hemangiosarcomas, leio- and rhabdomyosarcomas) supported the conclusion that MFH tumor cells originate from mesenchymal cells which do not belong to the mononuclear phagocytic system. Subdivision of the MFH tumors revealed that the storiform-pleomorphic subtypes could express HLA-Dr/Ia antigens, like histiocytic tumors. The inflammatory cell subtype, however, lacked these antigens...|$|R
50|$|Atypical fibroxanthoma of {{the skin}} is a low-grade {{malignancy}} related to malignant <b>fibrous</b> <b>histiocytoma,</b> which it resembles histologically.|$|E
50|$|Pleomorphic {{undifferentiated}} sarcoma (abbreviated PUS), also undifferentiated pleomorphic sarcoma {{and previously}} malignant <b>fibrous</b> <b>histiocytoma</b> (abbreviated MFH), {{is a type}} of soft tissue sarcoma.|$|E
50|$|Mundo Earwood was {{diagnosed}} with pancreatic cancer and a <b>fibrous</b> <b>histiocytoma</b> tumor in 2013, which led to his death {{at the age of}} 61.|$|E
40|$|Malignant <b>fibrous</b> <b>histiocytomas</b> (MFH) are {{the most}} {{commonly}} seen soft tissue sarcomas in adults. It is rarely seen in some visceral organs. Kidneys are the parenchymal organs in which MFHs are most frequently seen. More than 50 cases of primary renal MFH have been reported. Among these cases, only 1 was reported as primary giant cell subtype in association with urolithiasis. This case report is the second such case with the these characteristics...|$|R
40|$|Purpose: Soft tissue sarcomas (STS) {{account for}} less than 1 % of all {{malignancies}} and constitute a heterogeneous tumor entity in which malignant <b>fibrous</b> <b>histiocytomas</b> (MFH) represent one-third and are characterized {{by a lack of}} type-specific differentiation. A defective mismatch repair (MMR) system cause the familial cancer syndrome hereditary non-polyposis colorectal cancer (HNPCC), and since occasional MFH have been described in HNPCC patients we assessed the contribution of defective MMR to the development of MFH...|$|R
40|$|Myxofibrosarcoma (MFS) is {{a variant}} of the group of {{malignant}} <b>fibrous</b> <b>histiocytomas.</b> It {{is one of the most}} aggressive types of soft tissue neoplasms. The clinical presentation is not pathognomonic and the histological aspects are highly heterogenous, frequently delaying the diagnosis or leading to misdiagnosis. Complementary histochemical and immunohistochemical stainings are mandatory to achieve the diagnosis of MFS. A 78 -year-old male patient is presented illustrating this diagnostic pitfall. Extensive surgery followed by radiotherapy is the first choice treatment...|$|R
5000|$|Benign fibrous histiocytomas (also {{known as}} dermal dendrocytoma, dermatofibroma, fibrous dermatofibroma, [...] <b>fibrous</b> <b>histiocytoma,</b> fibroma simplex, nodular subepidermal fibrosis, and sclerosing hemangioma) are benign skin growths.|$|E
50|$|Malignant fibrous cytoma is a {{soft tissue}} sarcoma that usually {{occurs in the}} limbs, most {{commonly}} the legs, and may also occur in the abdomen. Also called malignant <b>fibrous</b> <b>histiocytoma.</b>|$|E
5000|$|Malignant <b>fibrous</b> <b>histiocytoma</b> (8830/3)(This is an {{obsolete}} {{term that}} is no longer recognized by the World Health Organization. Many of these tumors would currently be classified as [...] "undifferentiated pleomorphic sarcoma".) ...|$|E
40|$|Radiation-induced sarcomas are rare, {{high-grade}} sarcomas {{that may}} arise within the radiation field at a mean latency period of 3 - 55 years after radiation therapy, doses of {{which range from}} 45 to 60 Gy. Radiation-induced osteosarcomas, fibrosarcomas, and malignant <b>fibrous</b> <b>histiocytomas</b> are the most common. Wide resection with limb salvage or amputation is recommended for improved local control. Adjuvant radiation therapy and chemotherapy have not been shown to improve survival rates significantly. The prognosis is poor...|$|R
40|$|METHODS: We {{report on}} 15 {{patients}} surgically treated for intraparenchymal brain metastases from sarcoma, including six osteosarcomas, five leiomyosarcomas, two malignant <b>fibrous</b> <b>histiocytomas,</b> and two alveolar soft-part sarcomas (ASPS). RESULT: Median survival after craniotomy was 9. 3 months. Patients with a preoperative Karnofsky performance score of > 70 survived for 12. 8 versus 5. 3 months {{for those with}} a Karnofsky performance score 70 {{are associated with a}} favorable prognosis; the presence of concurrent lung metastases is not a contraindication to surgery...|$|R
40|$|Dermatofibromas ({{cutaneous}} <b>fibrous</b> <b>histiocytomas)</b> {{are common}} cutaneous neoplasms of mesenchymal origin. They are {{often associated with}} epidermal hyperplasia and increased basal layer pigmentation. There have been reports of a spectrum of melanocytic lesions associated with dermatofibromas ranging from junctional nevi to malignant melanomas, {{some of which may}} be coincidentally associated. We report a case of a long-standing storiform fibrohistiocytic lesion devoid of cytological atypia, lacking extension into subcutaneous fat, not demonstrating the t(17; 22) DFSP translocation yet showing diffuse and strong CD 34 immunoreactivity and containing pigmented spindle shaped melanocytic cells admixed with the fibrohistiocytic component. This case raises a nosological debate given the histological, immunophenotypic and cytogenetic findings...|$|R
50|$|Fusion of {{this gene}} and FUS on {{chromosome}} 16 or EWSR1 on chromosome 22 induced by translocation generates chimeric proteins in angiomatoid <b>fibrous</b> <b>histiocytoma</b> and clear cell sarcoma. This gene has a pseudogene on chromosome 6.|$|E
50|$|Other {{entities}} {{with similar}} clinical presentations include osteomyelitis, osteosarcoma (especially telangiectatic osteosarcoma), and eosinophilic granuloma. Soft-tissue neoplasms such as pleomorphic undifferentiated sarcoma (malignant <b>fibrous</b> <b>histiocytoma)</b> that erode into adjacent bone {{may also have}} a similar appearance.|$|E
50|$|In tumors, CD34 {{is found}} in {{alveolar}} soft part sarcoma, preB-ALL (positive in 75%), AML (40%), AML-M7 (most), dermatofibrosarcoma protuberans, gastrointestinal stromal tumors, giant cell fibroblastoma, granulocytic sarcoma, Kaposiâ€™s sarcoma, liposarcoma, malignant <b>fibrous</b> <b>histiocytoma,</b> malignant peripheral nerve sheath tumors, mengingeal hemangiopericytomas, meningiomas, neurofibromas, schwannomas, and papillary thyroid carcinoma.|$|E
40|$|Myxoid liposarcomas have {{a unique}} and {{specific}} t(12; 16) (q 13;p 11) chromosomal translocation. The breakpoint has recently been identified and shown to involve the TLS/FUS gene on chromosome 16 and the CHOP gene on chromosome 12. This translocation causes fusion of these genes resulting in {{the expression of a}} novel chimeric TLS/FUS-CHOP message. Using the polymerase chain reaction with primer sets derived from sequences of TLS/FUS and CHOP cDNAs, we could amplify three types of the fusion transcripts from seven of seven samples of myxoid and round cell liposarcomas. In six of the seven positive samples, two kinds of chimeric messenger RNAs were found that have been reported previously. However, the last sample had a novel chimeric message that had an extra sequence of 33 bp derived from the TLS/FUS gene. Thus, it was shown that these fusion transcripts had a varying extent of the sequence of TLS/FUS gene incorporated {{at the site of the}} fusion. However, the TLS/FUS-CHOP fusion transcripts were not detected in two pleomorphic liposarcomas or in three myxoid variants of malignant <b>fibrous</b> <b>histiocytomas.</b> Our findings indicate that in liposarcomas TLS/FUS-CHOP fusion transcripts have variations at the junction of chimeric messages, which was the case for Ewing's sarcoma. Detection of the chimeric message by reverse transcription polymerase chain reaction was also suggested to be a useful approach for the diagnosis of myxoid and round cell liposarcomas that have (12; 16) translocation, and for distinguishing them from pleomorphic liposarcoma and myxoid variant of malignant <b>fibrous</b> <b>histiocytomas...</b>|$|R
40|$|Forty-eight {{benign and}} {{malignant}} soft tissue tumors were investigated immunohistologically {{for the presence}} of laminin, a glycoprotein of basement membranes. The results showed intense laminin positivity in schwannomas and neurofibromas and less intense positivity in leiomyomas and leiomyosarcomas, whereas <b>fibrous</b> <b>histiocytomas</b> and fibrosarcomas generally were negative. It is suggested that immunohistochemical demonstration of laminin is a valuable aid in the differential diagnosis between tumors derived from fibroblasts and Schwann cells, and a potential aid in the differential diagnosis between tumors originating from fibroblasts and those from smooth muscle cells. In addition to the expression seen in the tumors, all vascular walls were positive for laminin. Therefore, demonstration of laminin also can be used to examine the vascular pattern of tumors. Peer reviewe...|$|R
40|$|The authors {{report their}} 27 -year {{experience}} regarding 35 cases of supratentorial brain metastasis from sarcoma {{treated in a}} single institution: these included ten osteosarcomas, seven leiomyosarcomas, five Ewing sarcomas, four malignant <b>fibrous</b> <b>histiocytomas,</b> three alveolar soft-part sarcomas (ASPS), two rhabdomyosarcomas, one liposarcoma, and three unclassified sarcomas. The first 15 cases of the series have already been described in a previous publication. Median survival after craniotomy was 9. 8 months (range: 4 - 24). In patients with preoperative Karnofsky performance score (KPS) > 60 it was 12. 8 months (range: 6. 5 - 24 months) versus 5. 4 months for those patients with a KPS 60 {{are associated with the}} best prognosis. Finally, it seems that surgical indications for multiple brain metastases from sarcom...|$|R
5000|$|Under light microscopy, {{the giant}} {{malignant}} pleomorphic cells {{making up a}} GCCL resemble those found in choriocarcinoma, angiosarcoma, and some forms of true sarcoma, such as malignant <b>fibrous</b> <b>histiocytoma</b> and rhabdomyosarcoma. In some instances, they can also bear considerable resemblance to [...] "activated" [...] histiocytes seen in some inflammatory conditions.|$|E
50|$|A {{reactive}} fibrohistiocytic lesion simulating <b>fibrous</b> <b>histiocytoma</b> {{has been}} reported by Snover et al. Reactive granular cells in sites of trauma have been regarded of histiocytic nature. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) might share several aspects of the XP. Likewise {{there might be some}} superimpositions between the XP and the plasma cell granuloma/histiocytoma-inflammatory myofibroblastic tumor complex.> The XP might be an important stage of this complex.|$|E
5000|$|While {{malignant}} <b>fibrous</b> <b>histiocytoma</b> (MFH) - now generally called [...] "pleomorphic undifferentiated sarcoma" [...] - {{primary in}} bone {{is known to}} occur occasionally, current paradigms tend to consider MFH a [...] "wastebasket" [...] diagnosis, and the current trend is toward using specialized studies (i.e. genetic and immunohistochemical tests) to classify these undifferentiated tumors into other tumor classes. Multiple myeloma is a hematologic cancer, originating in the bone marrow, which also frequently presents as one or more bone lesions.|$|E
40|$|AIM: To {{describe}} the clinicopathological features of 33 aneurysmal <b>fibrous</b> <b>histiocytomas</b> (AFH), including five cases with a haemangiopericytoma-like pattern. METHODS: Thirty three cases of AFH were studied by using routine histology and immunohistochemistry for factor XIIIa, the "cell activity marker" E 9 (anti-metallothionein), NK 1 C 3 (CD 57), smooth muscle actin (SMA), factor VIII, ulex europaeus agglutinin, JC 70 A (CD 31), and QBEND 10 (CD 34). The time dependent variation in histopathological features was evaluated by statistical methods (Pearson chi 2, likelihood ratio chi 2). RESULTS: Of the AFHs, 29 of 33 {{occurred on the}} extremities of adults (age range 30 to 50 years), six of which were associated with rapid growth, probably caused by trauma, and pain. Twenty one lesions {{were thought to be}} vascular and/or melanocytic lesions, including two melanomas, because of a bluish-black and/or cystic appearance. Histologically, large areas of haemorrhage, up to 50 % of the tumour bulk, lacking an endothelial lining were seen in otherwise typical <b>fibrous</b> <b>histiocytomas.</b> Five cases resembled nodular stages of Kaposi's sarcoma. Variable haemosiderin deposition in histiocytes (18 / 33) and giant cells (11 / 33) was suggestive of haemosiderotic histiocytoma. A haemangiopericytoma-like pattern was seen in five otherwise indistinguishable cases. On immunohistochemistry, variable reactivity was seen for factor XIIIa (18 / 30), with E 9 (18 / 30), NK 1 C 3 (19 / 30), and for SMA (14 / 30), but labelling for vascular markers was not detected. Early lesions without iron deposition were factor XIIIa positive; late lesions with iron deposition were factor XIIIa negative. Labelling for SMA correlated with prominent sclerosis. CONCLUSION: AFHs, including a haemangiopericytoma-like variant, have a characteristic time dependent histological and immunophenotypic profile, clearly different from nodular type Kaposi's sarcoma...|$|R
40|$|Abstract Background Benign <b>fibrous</b> <b>histiocytomas</b> (BFH) usually {{presents}} {{as a small}} benign lesion that predominantly {{occurs in}} the skin. Only few cases of BFH arising from bone have been reported, its occurrence in pelvic bones is even rarer. Case presentation A 34 -year-old female presented with BFH at a rare anatomical location {{on both sides of}} the os ilium which was larger than earlier reported BFH of the bone. Surgical resection was performed successfully including resection of the inner pelvic ring and reconstruction of the linea terminalis using a non-vascularized fibular autograft. At 18 months after tumor resection and reconstruction of the pelvic ring, with interposition of a free vascularized fibula graft patient has an excellent clinical oncological and functional outcome. Conclusion Non vascularized fibular autograft is a useful reconstructive procedure in select patients. </p...|$|R
40|$|PRUNE, {{the human}} {{homologue}} of the Drosophila gene, {{is located in}} 1 q 21. 3, a region highly amplified in human sarcomas, malignant tumours of mesenchymal origin. Prune protein interacts with the metastasis suppressor nm 23 -H 1, but shows impaired anity towards the nm 23 -H 1 S 120 G mutant associated with advanced neuroblas-toma. Based on these observations, we previously suggested that prune may act as a negative regulator of nm 23 -H 1 activity. We found amplification of PRUNE in aggressive sarcoma subtypes, such as leiomyosarcomas and malignant <b>fibrous</b> <b>histiocytomas</b> (MFH) {{as well as in}} the less malignant liposarcomas. PRUNE amplification was generally accompanied by high mRNA and moderate to high protein levels. The sarcoma samples expressed nm 23 -H 1 mostly at low or moderate levels, wherea...|$|R
